These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17935949)

  • 21. Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases.
    Kudoh S
    Am J Med; 2004 Nov; 117 Suppl 9A():12S-19S. PubMed ID: 15586559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.
    Fecik RA; Nguyen PL; Venkatraman L
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):741-7. PubMed ID: 16312149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
    Shteinberg M; Schneer S; Lavon O; Adir Y
    Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE; Rubin BK
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunomodulating effects of macrolides: areas of possible clinical use in pulmonology].
    Sinopal'nikov AI
    Ter Arkh; 2011; 83(8):10-20. PubMed ID: 21961326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: a promising strategy or an oriental mystery?
    Tateda K; Ishii Y; Kimura S; Horikawa M; Miyairi S; Yamaguchi K
    J Infect Chemother; 2007 Dec; 13(6):357-67. PubMed ID: 18095083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients.
    Maimon N; Lipton JH; Chan CK; Marras TK
    Bone Marrow Transplant; 2009 Jul; 44(2):69-73. PubMed ID: 19430505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.
    Altenburg J; de Graaff CS; van der Werf TS; Boersma WG
    Respiration; 2011; 81(1):75-87. PubMed ID: 20733282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical basis of macrolides apply in diseases of the respiratory tract].
    Płusa T
    Pol Merkur Lekarski; 2008 Nov; 25(149):432-6. PubMed ID: 19177783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
    Zarogoulidis P; Papanas N; Kioumis I; Chatzaki E; Maltezos E; Zarogoulidis K
    Eur J Clin Pharmacol; 2012 May; 68(5):479-503. PubMed ID: 22105373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrolides for the therapy of nosocomial infections.
    Mouktaroudi M; Giamarellos-Bourboulis EJ
    Curr Opin Infect Dis; 2012 Apr; 25(2):205-10. PubMed ID: 22248975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory therapy in cystic fibrosis.
    Dinwiddie R
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():45-8. PubMed ID: 16005266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azithromycin: mechanisms of action and their relevance for clinical applications.
    Parnham MJ; Erakovic Haber V; Giamarellos-Bourboulis EJ; Perletti G; Verleden GM; Vos R
    Pharmacol Ther; 2014 Aug; 143(2):225-45. PubMed ID: 24631273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic macrolide therapy in inflammatory airways diseases.
    Friedlander AL; Albert RK
    Chest; 2010 Nov; 138(5):1202-12. PubMed ID: 21051396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases.
    Kadota J; Mukae H; Tomono K; Kohno S; Nasu M
    Int J Antimicrob Agents; 2004 Dec; 24(6):550-4. PubMed ID: 15555876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-inflammatory effects of macrolides: applications in lung disease].
    Langelot M; Cellerin L; Germaud P
    Rev Pneumol Clin; 2006 Sep; 62(4):215-22. PubMed ID: 17075545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory effects of macrolides in childhood lung diseases.
    Luisi F; Gandolfi TD; Daudt AD; Sanvitto JP; Pitrez PM; Pinto LA
    J Bras Pneumol; 2012; 38(6):786-96. PubMed ID: 23288126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
    Dal Negro R; Micheletto C; Tognella S; Visconti M; Turati C
    Adv Ther; 2008 Oct; 25(10):1019-30. PubMed ID: 18821068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of macrolides and tetracyclines for chronic inflammatory diseases.
    Voils SA; Evans ME; Lane MT; Schosser RH; Rapp RP
    Ann Pharmacother; 2005 Jan; 39(1):86-94. PubMed ID: 15562139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse panbronchiolitis: role of macrolides in therapy.
    Keicho N; Kudoh S
    Am J Respir Med; 2002; 1(2):119-31. PubMed ID: 14720066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.